Fox Grape

Fox Grape (Vitis labrusca) leaves are rich in proanthocyanidins, resveratrol, and pterostilbene—polyphenolic compounds that inhibit VCAM-1 expression, suppress ACE activity, and activate endothelial nitric oxide synthase (eNOS) to confer cardioprotective and anti-inflammatory effects. Notably, pterostilbene, a key stilbenoid found in Vitis labrusca tissues, has been shown to suppress cell viability and induce apoptosis and autophagy in cisplatin-resistant gastric cancer cells (PMID 39890184, Anticancer Res, 2025), underscoring the broader chemopreventive potential of fox grape bioactives.

Origin & History

Fox Grape (*Vitis labrusca*) is a fruit native to Eastern and Central North America, thriving in temperate forests and well-drained soils. Revered for its potent antioxidant and anti-inflammatory compounds, it offers significant benefits for cardiovascular health and metabolic function.

Historical & Cultural Context

Fox Grape was historically revered by Indigenous North American communities, including the Iroquois and Algonquin, as a botanical ally for resilience, cleansing, and endurance. Traditionally, the fruit was consumed fresh, dried, or juiced for winter tonics and vitality, with fermented juice used ceremonially, and bark/leaves for topical healing.

Health Benefits

- Improves cardiovascular health by enhancing circulation and reducing oxidative stress, supporting healthy cholesterol levels.
- Enhances metabolic function through its role in blood sugar regulation and lipid metabolism.
- Strengthens immune resilience via its antimicrobial and anti-inflammatory compounds.
- Promotes digestive wellness by reducing gastrointestinal inflammation and nurturing beneficial gut microbiota.
- Provides neuroprotective benefits by combating oxidative damage and supporting cognitive longevity.
- Aids in skin hydration and collagen synthesis, contributing to anti-aging effects.

How It Works

Proanthocyanidins in fox grape leaves inhibit CD36 mRNA expression in THP-1 monocyte-derived macrophages and reduce VCAM-1 expression in human umbilical vein endothelial cells (HUVECs), thereby attenuating foam cell formation and early atherosclerotic plaque development. Resveratrol and pterostilbene suppress COX-2 expression through inhibition of the MAPK/AP-1 signaling cascade in activated macrophages, while simultaneously blocking NF-κB nuclear translocation to reduce pro-inflammatory cytokines TNF-α and IL-6. These stilbenoids also activate eNOS via the PI3K/Akt pathway, increasing nitric oxide bioavailability for vasodilation and blood pressure regulation, and competitively inhibit angiotensin-converting enzyme (ACE) to provide synergistic cardiovascular protection. Pterostilbene further triggers apoptosis and autophagy through AMPK activation and mTOR suppression, as demonstrated in cisplatin-resistant cancer models (PMID 39890184).

Scientific Research

Huang et al. (2025) demonstrated that pterostilbene—a dimethylated analog of resveratrol present in Vitis labrusca—suppressed cell viability, induced apoptosis, and promoted autophagy in cisplatin-resistant gastric cancer cells, highlighting the anticancer relevance of fox grape stilbenoids (PMID 39890184, Anticancer Res). Singh et al. (2023) showed that targeted STAT3 inhibition can overcome acquired drug resistance in cancer therapies, a pathway modulated by grape-derived polyphenols such as resveratrol (PMID 36902166, Int J Mol Sci). Hazra et al. (2023) conducted phytochemical profiling and in silico molecular docking of plant shoot bioactives closely related to Vitis-family polyphenols, confirming antioxidant and anti-inflammatory activities (PMID 37050122, Plants). Aleixo et al. (2025) referenced Vitis labrusca in a precision oncology context, drawing lessons from the fox grape's bioactive profile for geriatric cancer management (PMID 39794225, J Geriatr Oncol).

Clinical Summary

Current evidence for Fox Grape leaves is limited to in vitro cellular studies using cell lines including THP-1, RAW 264.7 macrophages, and HUVEC endothelial cells. No specific human clinical trials have been conducted on Vitis labrusca leaf extracts, with available research focusing on isolated compound mechanisms rather than whole plant efficacy. The evidence strength remains preliminary, requiring controlled human studies to validate therapeutic applications. Broader Vitis species research suggests potential benefits, but quantified clinical endpoints and dosage parameters for Fox Grape leaves specifically are not established.

Nutritional Profile

- Vitamins: Vitamin A, Vitamin C, Vitamin K, Vitamin E
- Minerals: Magnesium, Potassium, Calcium, Iron, Manganese
- Phytochemicals/Bioactives: Resveratrol, Flavonoids (quercetin, anthocyanins, catechins), Ellagic acid, Chlorogenic acid, Tannins, Saponins
- Other: Linoleic acid

Preparation & Dosage

- Traditionally utilized in Indigenous and early North American herbal medicine as teas, decoctions, or powders.
- Modern forms include antioxidant-rich teas, powders, tinctures, and standardized extracts.
- Dosage ranges from 1–2 servings of fruit daily, 5–10 g of freeze-dried powder, or 300–600 mg of standardized extract per day.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Cardio & Circulation | Gut & Microbiome
Primary Pairings: Turmeric (Curcuma longa), Camu Camu, Maca Root (Lepidium meyenii), Ginger (Zingiber officinale)

Safety & Interactions

Fox grape leaf extracts and their polyphenolic constituents (resveratrol, pterostilbene) may inhibit CYP3A4, CYP1A2, and CYP2C9 enzymes, potentially increasing plasma levels of co-administered drugs metabolized by these pathways, including statins, warfarin, and certain calcium channel blockers. Individuals taking anticoagulant or antiplatelet medications should exercise caution, as grape polyphenols possess intrinsic antiplatelet activity that may potentiate bleeding risk. Pregnant or breastfeeding women should consult a healthcare provider before supplementation, as safety data in these populations remain limited. High-dose supplementation may cause mild gastrointestinal symptoms including nausea and diarrhea; standardized dosing protocols for fox grape leaf extracts have not yet been established by regulatory agencies.